Clinical trial · Observational
Multivisceral Resections for Locally Advanced Gastric Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to assess whether the postoperative course and survival of patients subject to multivisceral resections for locally advanced gastric cancer (cT4b) were affected by the extent of surgery. An electronic database of 1476 patients with non-metastatic gastric cancer treated between January 1996 and December 2020 will be reviewed. The main questions it aims to answer are: * Does splenectomy, distal pancreatectomy or partial colectomy affect postoperative complications * What factors affect prognosis of patients with locally advanced gastric cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Extent od surgical resection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Complications
- timeFrame
- up to 90 days
- description
- Type and severity of complications graded by Clavien-Dindo scoring system (from 0 to 5, higher scores mean worse outcome)
- measure
- Survival
- timeFrame
- Overall survival from surgery to death or last follow up, whichever came first, assessed up to 60 months
- description
- Overall survival
Secondary outcomes (3)
- measure
- Rate of reoperations
- timeFrame
- up to 90 days
- description
- Reoperations
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * gastric adenocarcinoma * intraoperatively suspected infiltration of surrounding organs (stage cT4bN0-3bM0) * partial or total gastrectomy Exclusion Criteria: * distant metastases (M1) * gastrectomy combined with resection of organs other than spleen, pancreas, or colon
References
Publications (0)
Data not yet available